glp 1 eligibility Medicare GLP-1 Bridge Program 2026: Drugs, Costs, The Medicare GLP-1 Bridge is

Participants receiving once-weekly exenatide injections for 48 weeks showed modest improvements in motor scores compared to placebo, and these benefits persisted for 12 weeks after treatment cessation

doi: 10.1161/JAHA.116.004007

Busting some myths here

Khan MS, Fonarow GC, McGuire DK et al (2020) Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization

The theoretical concern is that a nursing infant exposed to semaglutide through breast milk could experience effects on their own GLP-1 signaling during a critical developmental window